CD8+ T cells induce graft vascular occlusion in a CD40 knockout donor/recipient combination

Journal of Heart and Lung Transplantation

Volumn 22, Issue 2, 2003, Pages 177-183

  Raisky, Olivier ^a   Spriewald, Bernd M ^b   Morrison, Karen J ^a   Ensminger, Stephan ^b   Mohieddine, Tarek ^a   Obadia, Jean Francois ^c   Yacoub, Magdi H ^a   Rose, Marlene L ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c LOUIS PRADEL HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR3; EOTAXIN; GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA; OKT 8; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT OCCLUSION; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE DEPLETION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECIPIENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD40; ARTERIAL OCCLUSIVE DISEASES; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; HEART TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUNICA INTIMA;

EID: 0037314181     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00465-5     Document Type: Article

References (32)

1. Grewal I.S., Flavell R.A. CD40 and CD154 in cell mediated immunity. Ann Rev Immunol. 16:1998;111-135.
2. Kawabe T., Naka T., Yoshida K., et al. The immune response in CD40-deficient mice Impaired immunoglobulin class switching and germinal centre formation. Immunity. 1:1994;167-178.
3. Grewal I.S., Xu J., Flavell R.A. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature. 378:1995;617-620.
4. + T cell responses. Immunol Today. 17:1996;410-414.
5. Caux C., Vanbervliet B., Massactier C., et al. Activation of human dendritic cells through CD40 cross-linking. J Exp Med. 180:1994;1263-1272.
6. Bennett S.R., Carbone F.R., Karamalis F., Flavell R.A., Miller J.F., Heath W.R. Help for cytotoxic T cell responses is mediated by CD40 signalling. Nature. 393:1998;478-480.
7. + T helper and a T-killer cell. Nature. 393:1998;474-478.
8. Larsen C.P., Alexander D.Z., Hollenbach D., et al. CD40-gp39 interactions play a critical role during allograft rejection. Transplantation. 61:1996;5-9.
9. Kirk A.D., Burkly L.C., Batty D.S., et al. Treatment with humanised monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med. 5:1999;686-693.
10. Parker D.C., Greiner D.L., Phillips N.E., et al. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci. 92:1995;9560-9564.
11. Hancock W.W., Buelow R., Sayegh M.H., Turka L.A. Antibody induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptopic genes. Nat Med. 4:1998;1392-1396.
12. Larsen C.P., Elwood E.T., Alexander D.Z., et al. Long term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 381:1996;434-438.
13. + T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade. Transplantation. 69:2000;2609-2612.
14. Trambley J., Bingman A.W., Lin A. Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade resistant allograft rejection. J Clin Invest. 104:1999;1715-1722.
15. + T cells can trigger allograft rejection. J Immunol. 165:2000;1111-1118.
16. + T cells. Transplantation. 70:2000;955-963.
17. Raisky O., Morrison K.J.M., Obadia J.F., McGregor J., Yacoub M.H., Rose M.L. Acute rejection and cardiac graft vasculopathy in the absence of donor derived ICAM-1 or P-selectin. J Heart Lung Transplant. 20:2001;340-349.
18. Raisanen-Sokolowski A., Glysing-Jensen T., Mottram P., Russell M. Sustained anti-CD4/CD8 blocks inflammatory activation and intimal thickening in mouse heart allografts. Arterioscler Thromb Vasc Biol. 17:1997;2115-2122.
19. Spriewald B.M., Hara M., Bushell A., Jenkins S., Morris P.J., Wood K.J. Differential role for competitive reverse transcriptase-polymerase chain reaction and intracellular cytokine staining as diagnostic tools for the assessment of intragraft cytokine profiles in rejecting and non-rejecting heart allografts. Am J Pathol. 157:2000;1453-1458.
20. Reiner S., Zheng S., Corry D.B., Locksley R.M. Constructing poly-competitor candies for quantitative PCR. J Immunol Met. 165:1993;37-46.
21. Gonzalo J.A., Lloyd C.M., Kremer L., et al. Eosinopil recruitment to the lung in a murine model of allergic inflammation The role of T cells, chemokines and adhesion receptors. J Clin Invest. 98:1996;2332.
22. Van Collie E., Van Damme J., Opdenakker G. The MCP/eotaxin subfamily of CC chemokines. Cyto Growth Factor Rev. 10:1999;61-86.
23. Ensminger S.M., Billing J.S., Morris P.J., Wood K.J. Development of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse. J Heart Lung Transplant. 19:2000;1039-1046.
24. Raisanen-Sokolowski A., Glysing-Jensen T., Koglin J., Russell M.E. Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-γ knock-out recipients. Am J Pathol. 152:1998;359-365.
25. Tellides G., Tereb D.A., Kirkiles-Smith N.C., et al. Interferon-γ elicits arteriosclerosis in the absence of leukocytes. Nature. 403:2000;207-211.
26. Border W.A., Ruoslahti E. Transforming growth factor-beta in disease The dark side of tissue repair. J Clin Invest. 90:1992;1-7.
27. Majesty M.W., Lindner V., Twardzik D.R., Schwartz S.M., Reidy M.A. Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest. 88:1991;904-910.
28. Mohamed M.A.S., Robertson H., Booth T.A., Balupuri S., Kirby J.A., Talbot T. TGF-β expression in renal transplant biopsies. Transplantation. 69:2000;1002-1005.
29. Ensminger S.M., Spriewald B.M., Sorensen H.V., et al. Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation. J Immunol. 167:2001;532-541.
30. Sallusto F., Mackay C.R., Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human helper 2 cells. Science. 277:1997;2005-2007.
31. Uguccioni M., Mackay C.R., Ochensberger B., et al. High expression of the chemokine receptor CCR3 in human blood basophils Role in activation by eotaxin, MCP-4 and other chemokines. J Clin Invest. 100:1997;1137-1143.
32. Haley K.J., Lilly C.M., Yang J.H., et al. Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis. Using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation. 102:2000;2185-2189.